Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Oster

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Experimental Cell Research|September 23, 1998
Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolismK A Foster, C G Oster, M M Mayer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 9, 2017
Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fracturesD Weycker, J Edelsberg, R Barron, et al.
International Journal of Technology Assessment in Health Care|January 1, 1992
A model for evaluating the cost-effectiveness of cholesterol-lowering treatmentH Glick, J F Heyse, D Thompson, et al.
Pharmaceutical Research|June 24, 2004
Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticlesChristine G Oster, Matthias Wittmar, Florian Unger, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 21, 2012
Adherence with bisphosphonate therapy and change in bone mineral density among women with osteoporosis or osteopenia in clinical practiceD Weycker, L Lamerato, S Schooley, et al.
MMW Fortschritte Der Medizin|November 9, 2012
[Generalized anxiety disorder in primary care. Patterns of healthcare utilization in Germany]H-U Wittchen, S Härtling, E Dukes, et al.
Journal of Human Hypertension|February 23, 2007
Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipineD Weycker, J Edelsberg, G Vincze, et al.
Diabetes Care|August 14, 1998
Potential economic benefits of lower-extremity amputation prevention strategies in diabetesD A Ollendorf, J G Kotsanos, W J Wishner, et al.
Journal of Human Hypertension|August 31, 2007
Risk of chronic kidney disease in hypertensive patients with other metabolic conditionsD Weycker, G A Nichols, M O'Keeffe-Rosetti, et al.
Rheumatology (Oxford, England)|March 22, 2008
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexateM Vera-Llonch, E Massarotti, F Wolfe, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Experimental Cell Research|September 23, 1998
Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolismK A Foster, C G Oster, M M Mayer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 9, 2017
Predictors of near-term fracture in osteoporotic women aged ≥65 years, based on data from the study of osteoporotic fracturesD Weycker, J Edelsberg, R Barron, et al.
International Journal of Technology Assessment in Health Care|January 1, 1992
A model for evaluating the cost-effectiveness of cholesterol-lowering treatmentH Glick, J F Heyse, D Thompson, et al.
Pharmaceutical Research|June 24, 2004
Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticlesChristine G Oster, Matthias Wittmar, Florian Unger, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 21, 2012
Adherence with bisphosphonate therapy and change in bone mineral density among women with osteoporosis or osteopenia in clinical practiceD Weycker, L Lamerato, S Schooley, et al.
MMW Fortschritte Der Medizin|November 9, 2012
[Generalized anxiety disorder in primary care. Patterns of healthcare utilization in Germany]H-U Wittchen, S Härtling, E Dukes, et al.
Journal of Human Hypertension|February 23, 2007
Risk of diabetes in a real-world setting among patients initiating antihypertensive therapy with valsartan or amlodipineD Weycker, J Edelsberg, G Vincze, et al.
Diabetes Care|August 14, 1998
Potential economic benefits of lower-extremity amputation prevention strategies in diabetesD A Ollendorf, J G Kotsanos, W J Wishner, et al.
Journal of Human Hypertension|August 31, 2007
Risk of chronic kidney disease in hypertensive patients with other metabolic conditionsD Weycker, G A Nichols, M O'Keeffe-Rosetti, et al.
Rheumatology (Oxford, England)|March 22, 2008
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexateM Vera-Llonch, E Massarotti, F Wolfe, et al.
Pageof 17